MicroRNA 141 represses nasopharyngeal carcinoma growth through inhibiting BMI1

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Distant metastasis is the primary cause of mortality in nasopharyngeal carcinoma (NPC).
• Understanding metastasis mechanisms is crucial for developing effective NPC treatments.
• MicroRNAs play significant roles in cancer progression and metastasis.

Purpose of the Study:

• To investigate the role of microRNA 141 (miR-141) in nasopharyngeal carcinoma (NPC) metastasis.
• To identify the molecular targets and signaling pathways regulated by miR-141 in NPC.
• To evaluate the potential of the miR-141/BMI1 axis as a therapeutic target for NPC.

Main Methods:

• Quantitative real-time PCR to assess miR-141 expression in NPC tissues and cell lines.
• In vitro assays (proliferation, invasion) to evaluate the functional role of miR-141.
• In vivo tumor growth inhibition studies.
• Western blotting and luciferase reporter assays to identify and validate BMI1 as a direct target of miR-141.
• Correlation analysis between miR-141/BMI1 expression and clinical parameters in NPC patients.

Main Results:

• miR-141 expression was significantly downregulated in NPC tumor cells, especially in metastatic samples.
• Ectopic expression of miR-141 suppressed NPC cell proliferation and invasion in vitro.
• miR-141 overexpression inhibited NPC tumor growth in vivo.
• BMI1 was identified as a direct target of miR-141, and its overexpression reversed the tumor-suppressive effects of miR-141.
• The miR-141/BMI1 signaling axis was found to correlate with the clinical stage and metastatic status of NPC patients.

Conclusions:

• Downregulation of miR-141 contributes to NPC progression and metastasis.
• The miR-141/BMI1 signaling pathway is a key regulator of NPC growth and invasion.
• Targeting the miR-141/BMI1 axis represents a promising therapeutic strategy for nasopharyngeal carcinoma.